» Articles » PMID: 6168835

Mechanism of Isoprenaline-induced Refractoriness of the Beta-adrenoceptor--adenylate Cyclase System in Chick Embryo Cardiac Cells

Overview
Date 1981 May 1
PMID 6168835
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the role of beta-adrenoceptors in regulating cardiac cell cyclic adenosine monophosphate (cyclic AMP) in concentrations during beta-receptor activation. Chick embryo cardiac cells in primary tissue culture respond to 50 microM isoprenaline with a rapid, but transient, increase in intracellular cyclic AMP. Continued exposure of these cells to this concentration of isoprenaline results in a rapid time-dependent decrease in maximum beta-receptor responsiveness. In vitro determination of adenylate cyclase and 125I-iodohydroxybenzyl pindolol specific beta-receptor binding sites in 35,000 x g particulate cell fractions and phosphodiesterase activity in cell homogenates suggest that the decrease in the cells' ability to raise intracellular cyclic AMP concentration is mainly due to an initial "uncoupling" of the beta-receptor--adenylate cyclase system. During 16 hr exposure of cells to varying isoprenaline concentrations, the magnitude of the cells' ability to increase intracellular cyclic AMP and the concentration of beta-receptor binding sites were inversely related to the isoprenaline concentration to which they had been previously exposed. On removal of isoprenaline, both beta-receptor response and receptor concentration returned slowly towards control levels over the next 24 hr. These results suggest that loss of beta-receptor responsiveness of cardiac cells during prolonged exposure to isoprenaline involves both alterations in receptor number and alterations of the adenylate cyclase system distal to the receptor.

Citing Articles

Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.

Osadchii O Heart Fail Rev. 2007; 12(1):66-86.

PMID: 17387610 DOI: 10.1007/s10741-007-9007-4.


Alterations in adrenergic receptor signaling in heart failure.

Lamba S, Abraham W Heart Fail Rev. 2005; 5(1):7-16.

PMID: 16228912 DOI: 10.1023/A:1009885822076.


Relation of iodine-123 metaiodobenzylguanidine myocardial scintigraphy to endomyocardial biopsy findings in patients with dilated cardiomyopathy.

Murata K, Kusachi S, Murakami T, Nogami K, Murakami M, Hirohata S Clin Cardiol. 1997; 20(1):61-6.

PMID: 8994740 PMC: 6656273. DOI: 10.1002/clc.4960200113.


Pharmacology and inotropic potential of forskolin in the human heart.

Bristow M, Ginsburg R, Strosberg A, Montgomery W, Minobe W J Clin Invest. 1984; 74(1):212-23.

PMID: 6330174 PMC: 425203. DOI: 10.1172/JCI111404.


The role of endogenous noradrenaline in the beta-blocker withdrawal phenomenon--studies with cultured heart cells.

Reithmann C, Thomschke A, Werdan K Klin Wochenschr. 1987; 65(7):308-16.

PMID: 2884347 DOI: 10.1007/BF01745384.